{
    "nctId": "NCT03833960",
    "briefTitle": "SLNB After Neoadjuvant Treatment in Node Positive Patients",
    "officialTitle": "Impact of Sentinel Lymph Node Biopsy After Neoadjuvant Treatment on Locoregional Control of Disease in Initially Node Positive Breast Cancer Patients",
    "overallStatus": "COMPLETED",
    "conditions": "Sentinel Lymph Node Biopsy, Locoregional Neoplasm Recurrence, Progression, Disease",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 65,
    "primaryOutcomeMeasure": "Regional recurrence",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* operable breast cancer submitted to neoadjuvant treatment in CHC Rijeka, followed by surgery in period from May 2016 till May 2018\n\nExclusion Criteria:\n\n* T4 stage\n* inflammatory breast cancer\n* M1 stage at the time of diagnose\n* bilateral disease\n* multicentric disease\n* unavailable complete required data",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}